Pancragen

Pancragen (Oral)

Pancragen is a synthetic peptide bioregulator originally developed from porcine pancreatic tissue extracts. In Eastern European ‘bioregulator’ research, it is studied for tissue‑specific signaling that may support pancreatic cellular homeostasis and stress resilience. Human clinical evidence is limited; most claims are based on preclinical or observational work from the peptide bioregulator literature.

Dosing Protocols

Common bioregulator research protocols use low milligram oral doses. Typical: 5–10 mg orally once daily, or 5 mg twice daily, for 10–20 days. Cycles are often repeated 2–3 times per year with ≥4–8 weeks off between courses.

Benefits

• Studied for support of pancreatic tissue homeostasis and cellular repair signaling
• May support exocrine pancreatic function markers in aging/stress models (limited evidence)
• Investigated for potential support of glucose homeostasis via pancreatic stress modulation (limited evidence)
• May influence inflammatory signaling pathways in pancreatic tissue (preclinical)
• Explored as an adjunct bioregulator in longevity/organ-support protocols (observational)
• Potential cytoprotective effects under oxidative or metabolic stress (preclinical)
• May support pancreatic microcirculation and trophic signaling (hypothesized)
• Investigated for support of post‑inflammatory tissue recovery (limited evidence)

Mechanism of Action

Bioregulator peptides are hypothesized to act as short tissue‑specific signaling fragments that modulate gene expression and protein synthesis in target cells. Proposed mechanisms include regulation of transcription/translation, normalization of cell cycle and apoptosis under stress, and modulation of local cytokine/oxidative pathways. For Pancragen specifically, the target organ is pancreatic tissue; direct receptor targets are not well characterized in accessible Western literature.

Side Effects

• GI upset (nausea, abdominal discomfort)
• Headache
• Fatigue
• Sleep changes
• Allergic reactions (rash, pruritus) in sensitive individuals
• Idiosyncratic changes in appetite

Side Effect Management

• Start low and titrate up over 3–7 days
• Take with food if nausea occurs
• Avoid stacking multiple new compounds simultaneously
• Stop use and seek medical care if allergic symptoms occur
• If blood sugar variability is a concern, monitor fasting glucose/CGM and discontinue if worsening

Contraindications

• Pregnancy or breastfeeding (insufficient safety data)
• Known allergy to peptide products or excipients
• History of severe pancreatitis without medical supervision
• Active malignancy (precaution due to growth/trophic signaling hypotheses)
• Severe hepatic/renal impairment (precaution)
• Children/adolescents (insufficient safety data)

Research Citations

PubMed/DOI-linked citations for verification. Many studies are preclinical (animal/in-vitro) or early clinical.

1. Khavinson V, Linkova N. Peptides: Prospects for Use in Aging and Age-Related Diseases. (review of peptide bioregulators). DOI Link
2. Ashmarin IP, Khavinson V. Regulatory peptides in biology and medicine (overview). DOI Link
3. Khavinson VKh, Malinin VV. Peptide regulation of gene expression (bioregulator concept). DOI Link

---